Gemcitabine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Gemcitabine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Sep 11, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-0182-25
- Dosage Form
- Injection
- Presentation
- Gemcitabine Hydrochloride, Injection, 2 g/52.6 mL (38 mg/mL), sterile solution in a single-dose glass vial NovaPlus (NDC 0409-0182-25)
- Initial Posting
- Sep 11, 2025